(Press-News.org) Supplementing testosterone significantly reduces heart attacks and strokes in men with unnaturally low levels of the hormone, according to new research presented at the European Association of Urology congress today.
The ten-year study involved over 800 men from Germany and Qatar with testosterone deficiency, whose family history, blood pressure, cholesterol levels, diabetes or weight put them at high risk of heart attack or stroke.
Only men with testosterone levels below normal, who also displayed symptoms of low testosterone, such as low mood, decreased appetite, depression, erectile dysfunction, loss of libido or weight gain, were included in the research.
Just over half of the men opted for long-term testosterone replacement therapy, enabling the researchers to compare this group to those whose condition was left untreated. All the men were encouraged to make lifestyle changes, in terms of diet, alcohol, smoking and exercise, to improve their cardiovascular health.
Of 412 men on testosterone therapy, 16 died and none suffered a heart attack or stroke. Of the 393 men who chose not to take testosterone supplements, 74 died, 70 had a heart attack and 59 suffered a stroke. Even when discrepancy in age was taken into account - the group taking testosterone was on average five years younger than the other group - these differences remained clear cut. For the men under 55, the risk of heart attack and stroke was reduced by 25 percent; for men over 60, the risk was reduced by 15 percent.
The health of the men on testosterone therapy also improved by other measures. They lost weight, had more lean muscle mass, their cholesterol level and liver function improved, their diabetes was better controlled and their blood pressure dropped.
Professor Omar Aboumarzouk, from the Hamad Medical Corporation in Qatar, explains: "Given that all these men would normally have been expected to suffer a heart attack or stroke in the next five to ten years, with no other intervention, it was a real surprise to see no cardiovascular events at all in the group on testosterone therapy. It's clear that this treatment can significantly reduce the risks in this particular group."
However, the team are keen to stress that testosterone therapy is not a silver bullet and should only be considered for patients who meet certain criteria.
"Testosterone can be seriously harmful if taken by men with normal levels, or who function perfectly well with reduced levels of the hormone," says Professor Aboumarzouk. "While men need testosterone for certain psychological and biological functions, only those with low levels who display other symptoms are likely to benefit from testosterone therapy.
"For those at high risk of heart attack and stroke, who are deficient in testosterone, it's likely that bringing the hormone back to normal levels helps them to maximise the benefits of other steps necessary to improve their overall health. This includes increasing exercise levels, eating healthier food, giving up smoking and reducing alcohol consumption.
"We believe that physicians treating patients with low testosterone, who are at high risk of heart attack or stroke, should consider testosterone therapy as one aspect of their treatment."
The study, which involved researchers from Dresden, Bremen and Muenster in Germany and Doha in Qatar, is still continuing.
Dr Maarten Albersen, Member of the EAU Scientific Office, from Leuven University in Belgium says: "The long-term cardiovascular risks or benefits of testosterone therapy are still unclear, because of conflicting results from previous research. This new study has shown a reduction in major cardiovascular events and mortality in men who received testosterone therapy, compared to men who opted not to receive this treatment.
"However, these were men with a medium risk of heart attack or stroke, and those receiving testosterone were younger and had a slightly lower risk at the start of the study. The study was long enough to see differences in the rate of cardiovascular events. However, the numbers involved and the fact that the trial was not randomised mean it's still difficult to draw any hard conclusions. A new trial is now underway, aiming to recruit 6000 participants, and this should provide definitive answers on the cardiovascular risks or even benefits of hormone therapy in men with low testosterone."
INFORMATION:
Outpatient antibiotic prescribing fell by almost 4% a year between 2011 and 2018, according to a study of prescribing patterns in the largest integrated health care system in the USA, being presented at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) held online this year.
Veterans Affairs (VA) facilities play a large role in the provision of outpatient care across the USA, providing care to over 9 million Veterans at more than 1,200 outpatient clinics.
The researchers speculate that the downward trend may be related to the antibiotic stewardship programmes widely implemented across the Veterans ...
New research presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) taking place online (9-12 July), suggests that three commonly prescribed classes of drugs that are not themselves antibiotics--proton pump inhibitors (PPIs), beta-blockers and antimetabolites--could lead to antibiotic resistant infections caused by bacteria from the Enterobacteriaceae family. These antibiotic resistant infections are in turn linked to longer hospital stays and potentially greater risk of death.
The observational study underscores the importance of commonly used non-antimicrobial drugs (NAMDs) as a risk factor for antibiotic resistance, researchers say.
Bacteria are thought to develop antibiotic resistance largely due to repeated exposure through over-prescribing, ...
*Note: this paper is being presented at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) and is being published in The Lancet Public Health. Please credit both the congress and the journal in your stories*
New research from Switzerland presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), held online this year, shows that people living in poorer neighbourhoods were less likely to be tested for COVID-19 but more likely to test positive, be hospitalised, or die, compared with those in more wealthy areas. The study is by Professor ...
A new study (the ATOMIC2 trial), presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) and published simultaneously in The Lancet Respiratory Medicine, shows the antimicrobial drug azithromycin - already approved for use in multiple infections - does not prevent mild COVID-19 cases progressing to hospitalisation or death.
The study, by Dr Timothy Hinks, John Radcliffe Hospital and University of Oxford, UK, and colleagues, shows that azithromycin should not be used as a treatment for COVID-19 and all countries must stop using it for this purpose, to prevent resistance developing to azithromycin in other infections.
The SARS-CoV-2 pandemic has not only started a rush to develop new treatments, but also investigations ...
For interviews with the report authors, please contact Dr Waasila Jassat, National Institute for Communicable Diseases of the National Health Laboratory Service, South Africa E) waasilaj@nicd.ac.za T) +27(0)82 927 4138
Alternative contact in the ECCMID Press Room: Tony Kirby T) + 44(0)7834 385827 E) tony@tonykirby.com or Rachael Davies T) +44(0)797 456 0784 E) rachaelvdavies@hotmail.co.uk
Notes to editors:
[1] Wave 1: (14721 deaths/59617625 SA population)*100,000 = 24.7 deaths per 100,000 people
Wave 2: (28682 deaths/59617625 SA population)*100,000 = 48.1 deaths per 100,000 ...
New research presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) shows the importance of receiving the second dose of a COVID-19 vaccine and also the need to constantly review and update vaccines to deal with new variants of concern. The study is by Dr Nicole Schneiderhan-Marra, Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany, and colleagues.
While vaccines have begun to bring the pandemic under control in certain countries, it remains unclear how effective these vaccines will continue to be as the virus mutates and evolves. The protection generated against the virus by vaccination is normally measured by antibodies, with a certain group ...
A presentation at this year's European Congress on Clinical Microbiology & Infectious Diseases (ECCMID), held online this year, will discuss the growing evidence that the beta SARS-CoV-2 variant first identified in South Africa is leading to more severe disease in people living with HIV, and that failure to clear SARS-CoV-2 infection in a patient with advanced HIV creates conditions that can lead to evolution of dangerous mutations in SARS-CoV-2.
Control of HIV with antiretroviral therapy could be the key to preventing such evolution of SARS-CoV-2 in patients with advanced HIV, since clearance of the virus is compromised if HIV is allowed to replicate for ...
Nashville, Tenn. (4:14 p.m. EDT--July 9, 2021)--Orthopedic surgeons know that knee surgeries that require revisions have inferior outcomes compared with primary surgeries but until now, the reason for this was unknown. Today a team of orthopedic physicians reports that opting for a transtibial surgical approach and choosing an inference screw for femoral and tibial fixation will improve the patient's odds of having a significantly better six-year clinical outcome.
The research was presented today at the American Orthopedic Society of Sports Medicine- Arthroscopy Association of North America Combined 2021 Annual Meeting by Rick Wright MD, ...
Sea otters are the smallest marine mammal. As cold-water dwellers, staying warm is a top priority, but their dense fur only goes so far. We have long known that high metabolism generates the heat they need to survive, but we didn't know how they were producing the heat -- until now.
Researchers recently discovered that sea otters' muscles use enough energy through leak respiration, energy not used to perform tasks, that it accounts for their high metabolic rate. The finding explains how sea otters survive in cold water.
Physiologist Tray Wright, research assistant professor in Texas A&M University's College of Education & Human Development, conducted the study along with colleagues ...
In the United States, nearly every pediatric doctor's visit begins with three measurements: weight, height and head circumference. Compared to average growth charts of children across the country, established in the 1970s, a child's numbers can confirm typical development or provide a diagnostic baseline to assess deviations from the curve. Yet, the brain, of vital importance to the child's development, is merely hinted at in these measurements.
Head circumference may indicate a head growth issue, which could be further investigated to determine if there is an issue with brain size or extra fluid. But now, in the age of ...
